연구성과로 돌아가기

2024 연구성과별 연구자 정보 (1679 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Kim, Hyun Kuk Kim, HK 2 Inje Univ, Dept Internal Med, Div Pulmonol, Haeundae Paik Hosp, Pusan, South Korea ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Jang, Tae Won Jang, TW 3 Kosin Univ, Dept Internal Med, Pulm Div, Gospel Hosp, Pusan, South Korea ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Seo, Hyewon Seo, H 4 Kyungpook Natl Univ Hosp, Dept Internal Med, Div Pulm Med, Daegu, South Korea ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Oh, Jee Youn Oh, JY 5 Korea Univ, Guro Hosp, Div Pulmonol, Dept Internal Med, Seoul, South Korea AAX-7147-2020 Oh, Jee ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Min, Jinsoo Min, J 6 Catholic Univ Korea, Seoul St Marys Hosp, Div Pulm & Crit Care Med, Dept Internal Med,Coll Med, Seoul, South Korea D-5181-2018 Min, Jinsoo 0000-0001-6091-518X Min, Jinsoo ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Kim, Ho Cheol Kim, HC 7 Gyeongsang Natl Univ, Changwon Hosp, Sch Med, Dept Internal Med, Chang Won, South Korea 0000-0002-3262-0672 KIM, HO CHEOL ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Shin, Ah Young Shin, AY 8 Inje Univ, Ctr Personalized Precis Med TB, Coll Med, Pusan, South Korea ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Shin, Ah Young Shin, AY 8 Catholic Univ Korea, Div Pulm & Crit Care Med, Dept Internal Med, Incheon St Marys Hosp,Coll Med, Seoul, South Korea ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Jayanti, Rannissa Puspita Jayanti, RP 9 Inje Univ, Ctr Personalized Precis Med TB, Coll Med, Pusan, South Korea ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Jayanti, Rannissa Puspita Jayanti, RP 9 Inje Univ, Dept Pharmacol, Coll Med, Pusan, South Korea ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Jayanti, Rannissa Puspita Jayanti, RP 9 Inje Univ, PharmacoGen Res Ctr, Coll Med, Pusan, South Korea ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Hung, Tran Minh Hung, TM 10 Inje Univ, Ctr Personalized Precis Med TB, Coll Med, Pusan, South Korea 0000-0002-7195-1079 Minh Hung, Tran ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Hung, Tran Minh Hung, TM 10 Inje Univ, Dept Pharmacol, Coll Med, Pusan, South Korea 0000-0002-7195-1079 Minh Hung, Tran ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Hung, Tran Minh Hung, TM 10 Inje Univ, PharmacoGen Res Ctr, Coll Med, Pusan, South Korea 0000-0002-7195-1079 Minh Hung, Tran ysncho@gmail.com;phshinjg@inje.ac.kr;
Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure Anh, Nguyen Ky Anh, NK 11 Inje Univ, Ctr Personalized Precis Med TB, Coll Med, Pusan, South Korea KBP-7253-2024 Nguyen Ky, Anh 0000-0001-9513-9563 Nguyen Ky, Anh ysncho@gmail.com;phshinjg@inje.ac.kr;
페이지 이동: